AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05749848 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [¹⁴C]-LY3372689
Description: Administered orally.
Study NCT05341258 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: EtCO2
Description: EtCO2
Study NCT05341258 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: PaCO2
Description: PaCO2
Study NCT04706702 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tele-EnhanceFitness
Description: Livestream, instructor-led tele-exercise classes, involving balance, endurance, and strength training
Study NCT04790058 — intervention group
Intervention type: OTHER
Intervention: Knowledge translation of the CSRS practice recommendations
Description: The intervention is knowledge translation of the CSRS practice recommendations; the application of the practice recommendations will occur during the patient's ED visit and patients who are eligible for 15-day cardiac rhythm monitoring will have Holter monitor applied at the time of ED discharge. For the secondary objective to validate the accuracy of the ultra-low risk criteria of CSRS and assess for potential improvements in the practice recommendations and the prediction models we will request verbal consent during the index ED visit for addition of cardiac biomarker measurements \[troponin and NT-proBNP\] for patients who did not have such measurements performed as part of routine clinical care, and a 30-day telephone follow-up for serious outcome assessment. Patients who do not consent will be excluded from these portions of the study but included in the health resource utilization and generic patient safety outcome assessment objectives.
Study NCT06457633 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experiential FW
Description: Traditional Fibrowalk based on Pain Science Education (30 min.) - Cognitive restructuring (30 min.) - Mindfulness techniques (30 min.) - Physical exercise in a natural environment / nature exposure (30 min.) carried out experientially.
Study NCT06457633 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional FW
Description: Traditional Fibrowalk based on Pain Science Education (30 min.) - Cognitive restructuring (30 min.) - Mindfulness techniques (30 min.) - Physical exercise in a natural environment / nature exposure (30 min.)
Study NCT06457633 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Online FW
Description: Traditional Fibrowalk based on Pain Science Education (30 min.) - Cognitive restructuring (30 min.) - Mindfulness techniques (30 min.) - Physical exercise in a natural environment / nature exposure (30 min.) performed virtually.
Study NCT05129267 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group B
Description: Scaling and Root debridement + iPRF
Study NCT05129267 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group C
Description: Scaling and Root debridement + iPRF together with vitamin C
Study NCT05140967 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (HIIT)
Description: High Intensity Interval Training
Study NCT05140967 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moderate Continuous Intensity Training (MICT)
Description: Moderate Intensity Continuous Training
Study NCT06274073 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dorsal digital block
Description: Dorsal regional digital block anesthesia (No drug or device is being investigated here; the two digital block procedure mentioned are compared)
Study NCT06274073 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Palmar digital block
Description: Palmar regional digital block anesthesia (No drug or device is being investigated here; the two digital block procedures mentioned are compared)
Study NCT06083961 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alirocumab
Description: Initial alirocumab, single dose of 300mg, subcutaneous injection
Study NCT05180708 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: QTORIN 3.9% rapamycin anhydrous gel
Description: QTORIN 3.9% rapamycin anhydrous gel
Study NCT05180708 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle
Description: Matching vehicle (QTORIN anyhydrous gel)
Study NCT04257266 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ice Pack Cooling
Description: 5 ice packs (Cryo cooling pack or commercial ice pack) will be placed on the subject for 30 mins after exercise-induced hyperthermia
Study NCT04257266 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ice Pack Cooling
Description: 5 ice packs (Cryo cooling pack or commercial ice pack) will be placed on the subject for 30 mins after exercise-induced hyperthermia
Study NCT05507385 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: IMAGINE-POSITIVE
Description: The intervention will combine aspects of Memory Specificity Training (MeST), which includes information about the links between memories and emotions, with Positive Prospective Mental Imagery (PPMI), to increase vividness and savouring of positive future images, in order to harness positive affect. IMAGINE-PA will follow a treatment manual and delivery will be accompanied by a therapy workbook.
Study NCT05507385 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Non-directive supportive therapy (NDST) consists of individual sessions, with an empathetic, emotionally supportive practitioner and provides non-directive problem solving and monitoring. Using NDST will control for factors that may contribute to change, which are not active components e.g. speaking to an empathetic therapist. NDST will follow treatment guidelines.
Study NCT05385458 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACT Intervention
Description: Acceptance and Commitment Therapy
Study NCT05385458 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Usual Care Services
Study NCT06339866 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Effect of Two Different Video Interventions on Pain and Anxiety in Children with Adenotonsillectomy: A Randomized Controlled Study
Description: The population of the study will be all patients who had adenotonsillectomy surgery between the ages of 6-12 in the Ear Nose and Throat Service of Zonguldak Bülent Ecevit University Hospital, and the sample will be all patients who had adenotonsillectomy surgery between the specified dates and who meet the inclusion criteria.
Study NCT05995314 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: PLACEBO
Description: 3 mg/kg of cellulose (0 mg/kg of caffeine)
Study NCT05995314 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 3 mg/kg of caffeine
Description: Ingestion of 3 mg/kg of body mass of caffeine
Study NCT05995314 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 6 mg/kg of caffeine
Description: Ingestion of 6 mg/kg of body mass of caffeine
Study NCT04684225 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hand Therapy via Telerehabilitation
Description: Hand Therapy via Telerehabilitation
Study NCT04684225 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hand Therapy via home-exercises
Description: Hand Therapy via home-exercises
Study NCT04670133 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Inulin
Description: Supplementation with a prebiotic, specifically inulin.
Study NCT04670133 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: Supplementation with maltodextrin (placebo)
Study NCT06398769 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SecuFix UM
Description: All surgeries were performed using Secufix UM.
Study NCT06398769 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: VCare UM
Description: All surgeries were performed using VCare UM.
Study NCT05987046 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contrast training
Description: Three sets of three repetitions of parallel squats at 90% of 1RM
Study NCT04630197 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: e-CBT
Description: The description is provided in the treatment arm description.
Study NCT05638152 — intervention group
Intervention type: OTHER
Intervention: implementation of a bundle of non-pharmacological interventions aimed at stress reduction
Description: The bundle consists of 4 interventions:~* natural imagery in the PACU (wall length decorations and lighted ceiling panels with sky views~* Aromatherapy with fragrances selected for anxiolytic and antiemetic properties~* Music available to patients~* Comfort Talk communication course for PACU nurses
Study NCT06422117 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HSK16149 20mg-40mg BID
Description: Oral, 20mg, BID, adjustable to 40mg, BID based on tolerability and efficacy;
Study NCT06422117 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo, oral, 2 capsules twice daily
Study NCT06395610 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CHF6001 DPI
Description: Single dose of CHF6001
Study NCT06395610 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erythromycin
Description: Repeated doses of oral Erythromycin
Study NCT05455905 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Patient Health Questionnaire-9
Description: The Patient Health Questionnaire-9 is a nine question self-administered examination in which the patient indicates how often they have experienced different feelings and sensations in the past two weeks. The Patient Health Questionnaire-9 is scored from 0 to 27 where higher scores are associated with more severe depression.
Study NCT05455905 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Generalized Anxiety Disorder-7
Description: The Generalized Anxiety Disorder-7 is a seven question self-administered examination in which the patient indicates how often they have experienced different feelings and sensations in the past two weeks. The Generalized Anxiety Disorder-7 is scored from 0 to 21 where higher scores are associated with more severe anxiety.
Study NCT05455905 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Hamilton Depression Rating Scale
Description: The Hamilton Depression Rating Scale is administered by a mental health profession and includes twenty-one questions asking about how the participant has been feeling in the past week. The Hamilton Depression Rating Scale is scored from 0 to 45 where higher scores are associated with more severe depression.
Study NCT05455905 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Hamilton Anxiety Rating Scale
Description: The Hamilton Anxiety Rating Scale is administered by a mental health profession and includes fourteen questions asking about how the participant has been feeling in the past week. The Hamilton Anxiety Rating Scale is scored from 0 to 56 where higher scores are associated with more severe anxiety.
Study NCT06181864 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NAO intervention
Description: The subjects will undergo a pre-intervention assessment phase that will consist of administering the Test of Emotional Vocabulary (TLE) and the Test of emotion comprehension (TEC). The tests will be re-submitted at the end of the intervention. Having ascertained the presence of the inclusion criteria and following randomization of the sample, the Experimental Group constituted of 20 children, will be administered the research task, which involves 15 sessions, one per week lasting one hour and thirty minutes. the children are guided by the voice of the robot Nao. The robot guides them in carrying out practical and relaxation activities. Consequently, audio visual feedback will be provided, via the robot, to return information to the subject about the accuracy of the response.
Study NCT06181864 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Traditional intervention
Description: The subjects will undergo a pre-intervention assessment phase that will consist of administering the Test of Emotional Vocabulary (TLE) and the Test of emotion comprehension (TEC). The tests will be re-submitted at the end of the intervention. Having ascertained the presence of the inclusion criteria and following randomization of the sample, the Experimental Group constituted of 20 children, will be administered the research task, which involves 15 sessions, one per week lasting one hour and thirty minutes. The children are guided by the instructions of the operator who guides them in carrying out practical and relaxation activities. Consequently, the operator will provide feedback, to return information to the subject regarding the accuracy of the response.
Study NCT05801731 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intervention
Description: The low GI snack is a biscuit with a Glycemic Index of 23.8 ± 3.3. The low GI snack contains plain flour, fibre, plant-based protein, vegetable oil and a low GI sweetener.~The interventional snacks (control, experimental) are matched for caloric content.
Study NCT05801731 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: The normal GI snack is a biscuit with a Glycemic Index of 54.4 ± 6.3. The control snack is formulated using basic ingredients for a biscuit recipe consisting of all-purpose flour, butter, sugar, vanilla flavour, baking soda, egg and salt.
Study NCT06370910 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Low-Level Laser Therapy
Description: The patient will be submitted to evaluation through a questionnaire, which will be the patient's evaluation form, which will be elaborated by the researcher (Appendix A). Next, pain and edema will be evaluated, using the VAS scales, Mc Gill scale and REEDA scale, after this process, the therapy will be applied, and the patient will be randomly selected for cryotherapy or LLLT. After application, the patient will be evaluated immediately and the scales applied again and after 24 hours.
Study NCT06333691 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Calcium Gluconate
Description: to compare the effectiveness of calcium gluconate, cabergoline and diosmin in preventing ovarian hyperstimulation syndrome in high-risk patient undergoing ICSI procedure.
Study NCT05154383 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Experimental arm : High-Dose Quadrivalent Influenza Vaccine (Efluelda)
Description: Patient will received one dose of High Dose Quadrivalent Influenza Vaccine according to marketing authorization.
Study NCT05154383 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparator: Standard-Dose Quadrivalent Influenza Vaccine
Description: Patient will received one dose of Standard Dose Quadrivalent Influenza Vaccine according to marketing authorization.
Study NCT05064852 — intervention group
Intervention type: DRUG
Intervention: Surufatinib
Description: The study is a real-world study. According to the actual medical history of patients, the usage of Surufatinib was collected.
Study NCT05699330 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bilateral subgenual cingulate deep brain stimulation (SGC DBS)
Description: Deep Brain Stimulation (DBS) is a neurosurgical procedure involving the implantation of deep brain electrodes, connected via a subcutaneous extension wire, to an implantable pulse generator (IPG, or 'battery') that is implanted below the collarbone. All patients will receive deep brain stimulation (DBS) targeting the subgenual cingulate (SGC) bilaterally. No other changes to pre-existing treatment will be made. This is the only arm in this experiment.
Study NCT06276933 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab + chemotherapy+Thalidomide
Description: Camrelizumab + chemotherapy+Thalidomide Drug: Camrelizumab Camrelizumab 200mg intravenous (IV) on Day 1 of each 21-day cycle，until progression or unacceptable toxicity Other Name: SHR-1210~Drug: Thalidomide Thalidomide 100mg，po qd； Other Name: Thalidomide~Drug: Chemotherapy~Platinum-based chemotherapy:~Non-small cell lung cancer (non-squamous cell carcinoma): pemetrexed plus carboplatin/cisplatin on Day 1 of each 21-day cycle for 4-6 cycles，pemetrexed every three weeks (Q3W) maintenance for the remainder of the study or until documented PD; Non-small cell lung cancer (squamous cell carcinoma) : paclitaxel/albumin-bound paclitaxel + carboplatin/cisplatin on Day 1 of each 21-day cycle for 4-6 cycles.~Other Name: Platinum-based chemotherapy
Study NCT06276933 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Camrelizumab + chemotherapy+placebo
Description: Drug: Camrelizumab Camrelizumab 200mg intravenous (IV) on Day 1 of each 21-day cycle，until progression or unacceptable toxicity Other Name: SHR-1210~Drug: placebo 100mg placebo 100mg，po qd；~Drug: Chemotherapy~Platinum-based chemotherapy:~Non-small cell lung cancer (non-squamous cell carcinoma): pemetrexed plus carboplatin/cisplatin on Day 1 of each 21-day cycle for 4-6 cycles，pemetrexed every three weeks (Q3W) maintenance for the remainder of the study or until documented PD; Non-small cell lung cancer (squamous cell carcinoma) : paclitaxel/albumin-bound paclitaxel + carboplatin/cisplatin on Day 1 of each 21-day cycle for 4-6 cycles.~Other Name: Platinum-based chemotherapy
Study NCT04756557 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental.
Description: Tooth Brushing HAP 2x daily repeated cleaning of all teeth 3 min. using a standardized electric tooth brush Electric (powered) toothbrushes (Oral-B; P\&G, Schwalbach, Germany), brushing head: medium; will be changed every 2 months and a non-fluoridated tooth paste containing microcrystalline hydroxyapatite . HAP-toothpaste (Karex toothpaste with 10 % hydroxyapatite) If a subject shows multiple carious lesions during the course of the study, the study dentist will decide whether the subject must be excluded from the study. In this case the subject will receive additional intensive caries prophylactic measures (e.g. chlorhexi-dine gel application, dietary counselling, etc.). Caries preventive treatment (removing caries and placing a restoration) by the study centers is offered.
Study NCT04756557 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active comparator
Description: Tooth Brushing F 2x daily repeated cleaning of all teeth 3min.using a standardized electric tooth brush ((Oral-B; P\&G, Schwalbach, Germany) and a fluoridated toothpaste (Karex Base with sodium fluoride 1450 F-), brushing head: medium; will be changed every 2 months If a subject shows multiple carious lesions during the course of the study, the study dentist will decide whether the subject must be excluded from the study. In this case the subject will receive additional intensive caries prophylactic measures (e.g. chlorhexidine gel application, dietary counselling, etc.). Caries preventive treatment (removing caries and placing a restoration) by the study centers is offered.
Study NCT04749732 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: WalkingPad plus Psychological Intervention - PsyWPad Group
Description: The 24-week walking program will be monitored by the WalkingPAD application that will accompany the patient on their walks and record their adherence to the previously defined individual program. Motivational support for a behavioral intervention will include two face-to-face sessions and the following contacts will be made over the phone. The behavioral motivational intervention will follow the principles of 1) motivational interview, will be based on 2) Theory of self-determination, taking into account 3) components of the Transtheoretical Model of Change and the Theory of Planned Behavior.
Study NCT04749732 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: WalkingPad plus Virtual Assistant - CyberWPad Group
Description: The 24-week walking program will be monitored by the WalkingPAD application, which will accompany the patient on their walks and record their adherence to the previously defined individual program. Motivational support will be provided by a virtual assistant through daily and on-the-spot interactions and through support and motivational messages.
Study NCT04749732 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: WalkingPad group - Paper WPad Group
Description: The 24-week walking program will be supported by a printed prescription of an individualized HbET previously defined on the WalkingPAD platform. However, this group of patients will not have the support of an application to monitor and record adherence to the program. Motivational support for a behavioral intervention will include two face-to-face sessions and the following contacts will be made over the phone. The behavioral motivational intervention will follow the principles of 1) motivational interview, will be based on 2) Theory of self-determination, taking into account 3) components of the Trans-Theoretical Model of Change and the Theory of Planned Behavior.
Study NCT04000841 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindful You mobile app
Description: The CRSR intervention consists of a native mobile application for Android and iOS devices. The mobile app includes:~* Guided meditations of varying length designed to connect the user to the present moment and a place of calm through culturally aligned exercises grounded in spirituality, orality, self-empowerment, and resilience.~* User-customized notifications prompting users to reflect and engage with the app, such as providing African American proverbs and quotes and asking simple questions like What are you grateful for today?~* Scheduled messages on the importance mindfulness as a way increase control over physical and psychological health~* User-customized reminders to do specific meditations and display personally selected images or messages.
Study NCT05387824 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Magnetic stimulation -Armchair type MS • NovaMag NT-60
Description: MS was applied two days a week, 20 minutes a day, a total of 12 sessions for 6 weeks.
Study NCT05387824 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrical Stimulation- TTNS
Description: TTNS were performed 2 days a week, for 30 min a day, for a total of 12 sessions for 6 weeks.
Study NCT05766059 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation
Description: The standard PAS protocol will be compared with the mirrorPAS protocol.